← Eichor
Condition: Pleural Metastases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pleural Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the L
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05354570Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZE
NA · 17 location(s) · University Hospital, Limoges · NCT06181357Phase II Trial of Lung Chemoemobolization
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT05672108A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07443020CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/Phase 2 · 5 location(s) · 7 Hills Pharma, LLC · NCT06362369A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Oxford Pleural Embolisation Trial
NA · 1 location(s) · Oxford University Hospitals NHS Trust · NCT06651658Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT05596578A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT06016179A Study of MT027 in Patients with Pleural Malignant Tumors
Phase 1 · 1 location(s) · Suzhou Maximum Bio-tech Co., Ltd. · NCT06726564Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00242723Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07325864Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
Phase 1 · 10 location(s) · InSilico Medicine Hong Kong Limited · NCT06566079
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.